TOFA – 50 mg

Brand:
Cayman
CAS:
54857-86-2
Storage:
-20
UN-No:
Non-Hazardous - /

Inhibition of fatty acid synthase (FASN) by the irreversible inhibitor cerulenin leads to cytotoxicity and apoptosis in human cancer cell lines.{11992} TOFA is an inhibitor of fatty acid synthesis blocking the synthesis of malonyl-CoA by acetyl-CoA carboxylase (ACC).{7659} Both cerulenin (at about 10 µg/ml) and TOFA (at about 1 µg/ml) are effective at blocking the incorporation of radiolabeled acetate into palmitate. However, TOFA reduces malonyl-CoA levels rather than elevating them, and TOFA is relatively non-toxic to various cancer cell lines. TOFA also attenuates the inhibition of feeding observed when FASN inhibitors such as cerulenin and C75 are administered to obese ob/ob mice.  

 

Available on backorder

SKU: 10005263 - 50 mg Category:

Description

An inhibitor of fatty acid synthesis that blocks the synthesis of malonyl-CoA by acetyl-CoA carboxylase (ACC)


Formal name: 5-(tetradecyloxy)-2-furancarboxylic acid

Synonyms:  5-(Tetradecyloxy)-2-furoic Acid|RMI 14514

Molecular weight: 324.5

CAS: 54857-86-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity